Real-World Evidence

Care Pathways Optimization

Providing a full spectrum of real-world evidence services

As part of Alira Health, the Care Factory team supports clients in all aspects of care pathways optimization, including:
  • Design of data models and study methodologies, including data set definition and analytics methodologies
  • Management of the SNDS process, including protocol of research, and procedure follow-up for the CESREES and CNIL
  • Data management and implementation of methodologies
  • Design of new remuneration models, including type of model (e.g., risk sharing performance), trackers, indicators, and methodologies
  • Impacts modeling and comparisons with existing solutions
  • Managing experts throughout the process

Data collection and sourcing

We collect the following data

  • Patient profiles, including age, gender, and welfare
  • Disease information, including diagnostic and co-morbidities
  • Drug prescriptions
  • Claims

Through these sources

  • Literature
  • Practitioners or coding expert interviews
  • SNIIRAM (event and total costs of care), EGB
  • PMSI (event during hospital stays)
  • CEPIDC (deceased cause)
  • Open data (open DAMIR)

Why partner with Alira Health and Care Factory?

Together, Alira Health and Care Factory provide services across the ecosystem for members of the healthcare industry looking to value the efficacy of care.

As innovative, market leaders in real-world evidence and data collection, we work closely with clients looking to experiment with new remuneration models, including performance, episodes, and yearly fees.

Care Pathways Optimization

Related News

News October 4, 2022
Alira Health enhances its market access services through a strategic partnership with Centivis
Alira Health, a global healthcare advisory and technology company, announced a strategic partnership with Centivis AG, a boutique market access consulting agency, specializing in digital(...)
Digital Health Market Access MedTech Pharma Regulatory
Events October 3, 2022
European Statistical Forum 2022
We are pleased to share that we will be joining the European Statistical Forum this year. This key for statistical experts event will include presentations on such topics as reproducibility,(...)
Biostatistics Data Science
Events September 30, 2022
XV Congresso Nazionale Sihta
We are pleased to share that we will be joining as speakers and sponsors XV Congresso Nazionale Sihta, a key event for Italian Healthcare industry.
Digital Health Real-World Evidence
Multimedia September 29, 2022
Regulatory Strategy for Registering Rare Disease Products in the EU
In this webinar we will focus on how to benefit, today and in the future, from the orphan drug program and build a regulatory strategy for successful rare disease product registration(...)
Drug Development Rare Disease Regulatory
News September 27, 2022
AseBio and Alira Health Partner to Foster Market Access for Biotech Startups
Alira Health and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.
Biotech Market Access Startups
Events September 20, 2022
Outsourcing in Clinical Trials New England 2022
We are excited to share that we will be attending and exhibiting at Outsourcing in Clinical Trials New England in Boston.
Clinical Operations Clinical Trials Healthcare Technology Hybrid Clinical Trials Rare Disease Trials
Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.